Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Medicenna Therapeutics Corp (MDNA.TO)

Medicenna Therapeutics Corp (MDNA.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
OTC Markets Group Welcomes Medicenna Therapeutics Corp. to OTCQX GlobeNewswire - Tue Oct 15, 6:00AM CDT

OTCM : 51.7600 (-4.10%)
MDNA.TO : 2.47 (+2.49%)
Medicenna to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) GlobeNewswire - Fri Oct 4, 8:07AM CDT

MDNAF : 1.7800 (+3.46%)
MDNA.TO : 2.47 (+2.49%)
Stocks in play: Medicenna Therapeutics Corp. Baystreet - Mon Sep 9, 8:53AM CDT

Announced today that, as planned and previously announced, new data from two of its preclinical programs ...

MDNA.TO : 2.47 (+2.49%)
Stocks in play: Medicenna Therapeutics Corp. Baystreet - Tue Aug 27, 8:50AM CDT

Will present two abstracts, both as oral presentations, at the Promise of Interleukin-2 Therapy Conference, ...

MDNA.TO : 2.47 (+2.49%)
Stocks in play: Medicenna Therapeutics Corp. Baystreet - Wed Apr 10, 9:26AM CDT

Presented updated clinical results from the monotherapy dose escalation and ongoing expansion portions ...

MDNA.TO : 2.47 (+2.49%)
Stocks in play: Medicenna Therapeutics Corp Baystreet - Thu Apr 4, 8:50AM CDT

Announced that CEO Dr. Fahar Merchant, President and CEO will present and participate in one-on-one ...

MDNA.TO : 2.47 (+2.49%)
Stocks in play: Medicenna Therapeutics Corp Baystreet - Wed Mar 6, 8:47AM CST

Announced today that two posters will be presented at the American Association for Cancer Research Annual ...

MDNA.TO : 2.47 (+2.49%)
Stocks in play: Medicenna Therapeutics Corp. Baystreet - Tue Feb 13, 8:48AM CST

Today announced the first patient dosed in the combination arm of the Phase 1/2 ABILITY (ABeta-only ...

MDNA.TO : 2.47 (+2.49%)
Stocks in play: Medicenna Therapeutics Corp. Baystreet - Tue Jan 9, 11:12AM CST

Today announced initiation of enrollment in the combination arm of the Phase 1/2 ABILITY (ABeta-only ...

MDNA.TO : 2.47 (+2.49%)

Barchart Exclusives

Can the REMX ETF Rally? Barchart - 35 minutes ago
While the REMX ETF’s name implies significant exposure to rare earth metals and minerals, the product’s holdings are primarily invested in lithium-producing mining companies. REMX has been under pressure, but commodity cyclicality suggests that it is in the buying zone below $50 per share. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot